Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,827 | 155,579 | 42,299 | 45,897 | 24,846 |
| Marketable Securities | 374,543 | 268,971 | 154,666 | 81,742 | 1,999 |
| Other current assets | 102 | 102 | 451 | 0 | 0 |
| TOTAL | $486,478 | $431,173 | $200,163 | $129,611 | $29,739 |
| Non-Current Assets | |||||
| PPE Net | 1,672 | 1,326 | 375 | 309 | 523 |
| Other Non-Current Assets | 2,274 | 2,592 | 3,171 | 1,335 | 0 |
| TOTAL | $3,946 | $3,918 | $3,546 | $1,644 | $523 |
| Total Assets | $490,424 | $435,091 | $203,709 | $131,255 | $30,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,239 | 14,234 | 2,329 | 670 | 1,096 |
| Accrued Expenses | 24,108 | 18,827 | 11,018 | 9,703 | 5,108 |
| TOTAL | $26,635 | $33,349 | $13,636 | $10,674 | $10,180 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,205 | 4,645 | N/A | N/A | 4,328 |
| Deferred Revenues | 288 | 288 | 289 | 301 | N/A |
| aiOther Non-Current Liabilities | 989 | 1,172 | 1,208 | 544 | 0 |
| TOTAL | $21,767 | $6,678 | $2,357 | $544 | $4,328 |
| Total Liabilities | $48,402 | $40,027 | $15,993 | $11,218 | $14,508 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,768 | 42,898 | 25,913 | 7,231 | 3,540 |
| Common Shares | 540 | 414 | 239 | 42 | 23 |
| Retained earnings | -725,908 | -488,174 | -358,300 | -278,887 | -168,169 |
| Other shareholders' equity | 206,854 | 141,757 | 133,676 | 180,793 | 0 |
| TOTAL | $442,022 | $395,064 | $187,716 | $120,037 | $15,754 |
| Total Liabilities And Equity | $490,424 | $435,091 | $203,709 | $131,255 | $30,262 |